89 related articles for article (PubMed ID: 27221921)
1. VEGFR2 Expression in Head and Neck Squamous Cell Carcinoma Cancer Cells Mediates Proliferation and Invasion.
Xu HM; Zhu JG; Gu L; Hu SQ; Wu2 H
Asian Pac J Cancer Prev; 2016; 17(4):2217-21. PubMed ID: 27221921
[TBL] [Abstract][Full Text] [Related]
2. Targeting of EZH2 inhibits epithelial‑mesenchymal transition in head and neck squamous cell carcinoma via regulating the STAT3/VEGFR2 axis.
Zhao M; Hu X; Xu Y; Wu C; Chen J; Ren Y; Kong L; Sun S; Zhang L; Jin R; Zhou X
Int J Oncol; 2019 Nov; 55(5):1165-1175. PubMed ID: 31545422
[TBL] [Abstract][Full Text] [Related]
3. VEGFR2 inhibition by RNA interference affects cell proliferation, migration, invasion, and response to radiation in Calu-1 cells.
Liu Y; Qiao Y; Hu C; Liu L; Zhou L; Liu B; Chen H; Jiang X
Clin Transl Oncol; 2016 Feb; 18(2):212-9. PubMed ID: 26459253
[TBL] [Abstract][Full Text] [Related]
4. Involvement of CD74 in head and neck squamous cell carcinomas.
Kindt N; Lechien JR; Nonclercq D; Laurent G; Saussez S
J Cancer Res Clin Oncol; 2014 Jun; 140(6):937-47. PubMed ID: 24663824
[TBL] [Abstract][Full Text] [Related]
5. The upregulated α-catulin expression was involved in head-neck squamous cell carcinogenesis by promoting proliferation, migration, invasion, and epithelial to mesenchymal transition.
Zhang Z; Yang XF; Huang KQ; Ren L; Zhao S; Gou WF; Shen DF; Sun HZ; Takano Y; Zheng HC
Tumour Biol; 2016 Feb; 37(2):1671-81. PubMed ID: 26311049
[TBL] [Abstract][Full Text] [Related]
6. EGFR antisense treatment of human HNSCC cell lines down-regulates VEGF expression and endothelial cell migration.
Riedel F; Götte K; Li M; Hörmann K; Grandis JR
Int J Oncol; 2002 Jul; 21(1):11-6. PubMed ID: 12063543
[TBL] [Abstract][Full Text] [Related]
7. Regulation of invasive behavior by vascular endothelial growth factor is HEF1-dependent.
Lucas JT; Salimath BP; Slomiany MG; Rosenzweig SA
Oncogene; 2010 Aug; 29(31):4449-59. PubMed ID: 20498643
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor receptor 2 (VEGFR2) expression in squamous cell carcinomas of the head and neck.
Neuchrist C; Erovic BM; Handisurya A; Steiner GE; Rockwell P; Gedlicka C; Burian M
Laryngoscope; 2001 Oct; 111(10):1834-41. PubMed ID: 11801954
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of IQGAP1 promotes the angiogenesis of esophageal squamous cell carcinoma through the AKT and ERK‑mediated VEGF‑VEGFR2 signaling pathway.
Li CH; Sun XJ; Niu SS; Yang CY; Hao YP; Kou JT; Li XZ; Wang XX
Oncol Rep; 2018 Sep; 40(3):1795-1802. PubMed ID: 30015941
[TBL] [Abstract][Full Text] [Related]
10. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma.
Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY
Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinomas of the head and neck.
Sauter ER; Nesbit M; Watson JC; Klein-Szanto A; Litwin S; Herlyn M
Clin Cancer Res; 1999 Apr; 5(4):775-82. PubMed ID: 10213212
[TBL] [Abstract][Full Text] [Related]
12. Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma.
Dong G; Chen Z; Li ZY; Yeh NT; Bancroft CC; Van Waes C
Cancer Res; 2001 Aug; 61(15):5911-8. PubMed ID: 11479233
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor in squamous cell head and neck carcinoma: expression and prognostic significance.
Salven P; Heikkilä P; Anttonen A; Kajanti M; Joensuu H
Mod Pathol; 1997 Nov; 10(11):1128-33. PubMed ID: 9388064
[TBL] [Abstract][Full Text] [Related]
14. Dysregulation of junctional adhesion molecule-A via p63/GATA-3 in head and neck squamous cell carcinoma.
Kakuki T; Kurose M; Takano K; Kondoh A; Obata K; Nomura K; Miyata R; Kaneko Y; Konno T; Takahashi S; Hatakeyama T; Kohno T; Himi T; Kojima T
Oncotarget; 2016 Jun; 7(23):33887-900. PubMed ID: 27036044
[TBL] [Abstract][Full Text] [Related]
15. Human head and neck squamous cell carcinoma cells are both targets and effectors for the angiogenic cytokine, VEGF.
Tong M; Lloyd B; Pei P; Mallery SR
J Cell Biochem; 2008 Dec; 105(5):1202-10. PubMed ID: 18802921
[TBL] [Abstract][Full Text] [Related]
16. Expression of vascular endothelial growth factor receptors on tumor cells in head and neck squamous cell carcinoma.
Lalla RV; Boisoneau DS; Spiro JD; Kreutzer DL
Arch Otolaryngol Head Neck Surg; 2003 Aug; 129(8):882-8. PubMed ID: 12925349
[TBL] [Abstract][Full Text] [Related]
17. RhoC mediates epidermal growth factor-stimulated migration and invasion in head and neck squamous cell carcinoma.
Tumur Z; Katebzadeh S; Guerra C; Bhushan L; Alkam T; Henson BS
Neoplasia; 2015 Jan; 17(1):141-51. PubMed ID: 25622907
[TBL] [Abstract][Full Text] [Related]
18. p38alpha and p38delta mitogen-activated protein kinase isoforms regulate invasion and growth of head and neck squamous carcinoma cells.
Junttila MR; Ala-Aho R; Jokilehto T; Peltonen J; Kallajoki M; Grenman R; Jaakkola P; Westermarck J; Kähäri VM
Oncogene; 2007 Aug; 26(36):5267-79. PubMed ID: 17334397
[TBL] [Abstract][Full Text] [Related]
19. Dasatinib (BMS-354825) tyrosine kinase inhibitor suppresses invasion and induces cell cycle arrest and apoptosis of head and neck squamous cell carcinoma and non-small cell lung cancer cells.
Johnson FM; Saigal B; Talpaz M; Donato NJ
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6924-32. PubMed ID: 16203784
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 expression in squamous cell carcinomas of the head and neck.
Neuchrist C; Erovic BM; Handisurya A; Fischer MB; Steiner GE; Hollemann D; Gedlicka C; Saaristo A; Burian M
Head Neck; 2003 Jun; 25(6):464-74. PubMed ID: 12784238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]